Monosaccharides

a-L-Fucose-1-phosphate is a Glycosylation, complex carbohydrate, Methylation, Click modification, Polysaccharide, Fluorination, saccharide, Modification, sugar, Oligosaccharide and Synthetic product. a-L-Fucose-1-phosphate is available for custom synthesis and can be ordered with high purity.

1,4-Dideoxy-1,4-imino-D-xylitol HCl (DDX) is a potent inhibitor of the enzyme carboxypeptidase A2. DDX has been shown to inhibit the growth of HIV in vitro and in vivo. DDX also inhibits the production of proinflammatory cytokines and neurotrophic factors from HL60 cells. It has been shown to be a potential drug target for the treatment of infectious diseases such as alphaviruses, which produce a severe neuroinvasive disease in humans. DDX binds to dna with high affinity and specificity, but does not bind to RNA or proteins. DDX inhibits mitochondrial membrane potential by binding to ATP synthase and blocking the synthesis of ATP. DDX has also been shown to have an anti-oxidative injury effect on mitochondria, which may contribute to its inhibition of viral replication.

Glufosfamide is a cytotoxic drug that is used in the treatment of some types of cancer. It is a prodrug that requires conversion to its active form, glufosfamid, by esterase enzymes before it can exert its genotoxic effects. Glufosfamide has shown to be active against platinum-resistant ovarian cancer and solid tumours. This drug also has been shown to inhibit the growth of prostate cancer cells and miapaca-2 cells, which are derived from pancreatic cancer. Glufosfamide has been found to have low toxicity in mice, but there may be adverse reactions when combined with other drugs such as erythromycin or ketoconazole.

5-Deoxy-L-lyxono-1,4-lactone is a crystalline solid that belongs to the class of hydroxamic acids. This compound has been shown to react with hydroxylamine in an aldonic reaction and to inhibit the enzyme xanthin oxidase. The monoclinic crystal structure of 5-Deoxy-L-lyxono-1,4-lactone was determined by XRD analysis. This compound is synthesized from glyoxylate and malonitrile in an efficient manner. It also inhibits glucose oxidation and can be used as an additive for food products.

(R)-Ketoprofen b-D-glucuronide is a synthetic modified sugar that is produced by the glucuronidation of ketoprofen, a nonsteroidal anti-inflammatory drug. The modification of ketoprofen with glucuronic acid can be achieved through an enzymatic process, which is catalyzed by UDP-glucuronyltransferase. This modification increases the solubility of ketoprofen and its ability to penetrate cells. (R)-Ketoprofen b-D-glucuronide has been shown to have antibacterial properties against Gram positive bacteria such as Staphylococcus aureus and Streptococcus pyogenes. It has also shown antiviral activity against HIV-1 due to its inhibition of reverse transcriptase, which is an enzyme important for viral replication.

1,2,3,4-Tetra-O-acetyl-D-xylopyranose is a molecule that is derived from D-xylose. It has been shown to inhibit the growth of fungi such as T. rubrum and L. candidum by acetylation of l-threonine at the C2 position. This molecule can be recycled and its inhibitory activity can be increased through acetylation of the hydroxymethyl group on the C4 position. The mechanism of inhibition is not known but it may be due to steric hindrance or peracylation.